Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort Consortium.
Julia ButtWilliam J BlotKala VisvanathanLoïc Le MarchandLynne R WilkensYu ChenHoward D SessoLauren R TerasMarc D RyserTerry HyslopSylvia Wassertheil-SmollerLesley F TinkerJohn D PotterMingyang SongSonja I BerndtTim WaterboerMichael PawlitaMeira EppleinPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
Our finding suggests that p53 seropositivity may not be a useful predictor of long-term colorectal cancer risk; however, it might be considered as a marker to aid in the early diagnosis of colorectal cancer.
Keyphrases